{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:12:06Z","timestamp":1760267526640,"version":"3.37.3"},"reference-count":5,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nodular lymphocyte\u2010predominant Hodgkin lymphoma (<jats:styled-content style=\"fixed-case\">NLPHL<\/jats:styled-content>) is a rare lymphoma (&lt;5% of Hodgkin\u2019s lymphomas) predominantly affecting the middle\u2010aged man, with an indolent behavior. Given the rare occurrence of this lymphoma, there are currently no clear guidelines for initial treatment or relapse. In this report, we present the follow\u2010up of 2 patients treated by radioimmunotherapy for first relapse of their <jats:styled-content style=\"fixed-case\">NLPHL<\/jats:styled-content>. Both patients were initially treated with rituximab and relapsed 1\u00a0year after the end of their treatment.<\/jats:p>","DOI":"10.1111\/ejh.13087","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T23:50:20Z","timestamp":1525305020000},"page":"415-417","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long\u2010term follow\u2010up of 2 patients treated with <sup>90<\/sup>Y\u2010rituximab radioimmunotherapy for relapse of nodular lymphocyte\u2010predominant Hodgkin lymphoma"],"prefix":"10.1111","volume":"101","author":[{"given":"Sophie C.","family":"Golstein","sequence":"first","affiliation":[{"name":"Department of Hematology Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoff","family":"Muylle","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Vercruyssen","sequence":"additional","affiliation":[{"name":"Department of Hematology Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Spilleboudt","sequence":"additional","affiliation":[{"name":"Department of Hematology Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de Wind","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-1104","authenticated-orcid":false,"given":"Dominique","family":"Bron","sequence":"additional","affiliation":[{"name":"Department of Hematology Institut Jules Bordet (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2578-6"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-453241"},{"key":"e_1_2_5_4_1","first-page":"394","article-title":"Safety and efficacy of radioimmunotherapy with 90Yttrium\u2010rituximab in patients with relapsed CD20+ B cell lymphoma: a feasibility study","volume":"4","author":"Vaes M","year":"2012","journal-title":"J Cancer Sci Ther"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0372-y"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.321"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.13087","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T16:04:28Z","timestamp":1694966668000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.13087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1111\/ejh.13087"],"URL":"https:\/\/doi.org\/10.1111\/ejh.13087","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"2018-03-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}